Narrative review / 2012
Antioxidant compounds such as N-acetyl-cysteine and curcumin show promise as potential co-adjuvants in depression treatment.
This review examines the potential role of oxidative stress processes in the pathogenesis of depression and discusses antioxidants as co-adjuvants to standard antidepressants. Major depression has been linked to decreased concentrations of endogenous antioxidants such as vitamin E, zinc, coenzyme Q10, and glutathione peroxidase, as well as impaired total antioxidant status. In human clinical evidence, N-acetyl-cysteine demonstrated significant benefit on depressive symptoms in a randomized placebo-controlled trial. Additionally, curcumin has shown antidepressant activity in various animal models of depression, partly through monoamine oxidase inhibition.
- Study type
- Narrative review
- Who was studied
- Individuals with major depression and animal models of depression
- What was measured
- Role of oxidative stress and therapeutic potential of antioxidants in depression
THE PAPER
Antioxidants as antidepressants: fact or fiction?
Scapagnini G, Davinelli S, Drago F, De Lorenzo A, Oriani G. CNS Drugs, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.